TransCode Therapeutics
Balance Sheet

Last updated:

The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has TransCode Therapeutics's balance sheet done over the years? Its assets were worth $5,169,701 last year, which is less than in the previous period. 68% of TransCode Therapeutics’s total assets is currently financed by debt. Its liabilities reached the amount of $3,528,887, which means an decrease by -19% compared compared to last year.

Debt to Assets

TransCode Therapeutics, Inc. (NASDAQ:RNAZ): Debt to assets
2019 204471 1.31M 642.76%
2020 1055368 4.46M 422.94%
2021 22938443 2.53M 11.05%
2022 7587986 4.34M 57.29%
2023 5169701 3.52M 68.26%

RNAZ Balance Sheet (2019 – 2023)

2023 2022 2021 2020 2019
Assets
Current assets:
Cash and cash equivalents
2.76M4.96M20.82M828.01K204.47K
Short term investments
09930
Net receivables
0360.22K000
Inventory
0554.33K000
Other current assets
1.67M1.49M1.83M3.19K0
Total current assets
4.45M7.37M22.73M831.21K204.47K
Non-current assets:
Property, Plant and Equipment
602.40K208.58K206.26K00
Goodwill
00000
Intangible assets
00000
Long term investments
00012.76K12.27K
Other non-current assets
111.85K-7-3211.39K-1
Total non-current assets
714.25K208.58K206.26K224.15K12.27K
Total assets
5.16M7.58M22.93M1.05M204.47K
Liabilities
Current liabilities:
Accounts payable
Deferred revenue
27.05K030.52K00
Short term debt
412.28K0-2.01M00
Total current liabilities
3.49M4.34M2.53M404.86K62.94K
Non-current liabilities:
Long term debt
38.29K002.08M927.81K
Deferred tax
00000
Other non-current liabilities
04.34M01.97M323.50K
Total non-current liabilities
38.29K4.34M04.05M1.25M
Total liabilities
3.52M4.34M2.53M4.46M1.31M
Data sourceData sourceData source